Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1999-2-16
|
pubmed:abstractText |
Serum alanine transaminase (ALT) levels are used to select hepatitis C virus (HCV)-infected patients for treatment and liver biopsy. However, the natural history of these measurements is poorly understood. To examine the hypothesis that ALT levels vary over time in HCV-infected patients, serial serum ALT levels were prospectively measured in a cohort of 1,235 persons with a history of prior illicit drug use. Over 25 months of follow-up, there was a median of four evaluations per patient. ALT values were higher in 1,164 (94%) HCV-infected individuals than in 71 (6%) HCV-uninfected individuals. The remainder of the analysis focused on these HCV-infected individuals, 647 (62%) of whom had normal ALT values at their initial visit. However, 323 (49%) of these had at least one elevated ALT over the next 25 months. Of the 395 patients whose ALT was initially abnormal, 332 (84%) had at least one normal value over the next 25 months. Overall, among individuals with four or more visits, ALT values were persistently normal in 42%, persistently elevated in 15%, and intermittently elevated in 43%. Because serum ALT levels have high visit-to-visit variability, single assessments should not be used to manage HCV-infected individuals. Further investigation is needed to ascertain the correlation of serial ALT trends with important disease outcomes.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0270-9139
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
590-6
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9918940-Adult,
pubmed-meshheading:9918940-Alanine Transaminase,
pubmed-meshheading:9918940-Biopsy,
pubmed-meshheading:9918940-Community Health Services,
pubmed-meshheading:9918940-Female,
pubmed-meshheading:9918940-HIV Infections,
pubmed-meshheading:9918940-Hepacivirus,
pubmed-meshheading:9918940-Hepatitis C,
pubmed-meshheading:9918940-Humans,
pubmed-meshheading:9918940-Liver,
pubmed-meshheading:9918940-Male,
pubmed-meshheading:9918940-Prospective Studies,
pubmed-meshheading:9918940-RNA, Viral,
pubmed-meshheading:9918940-Substance Abuse, Intravenous
|
pubmed:year |
1999
|
pubmed:articleTitle |
A prospective, community-based evaluation of liver enzymes in individuals with hepatitis C after drug use.
|
pubmed:affiliation |
Divisions of Infectious Diseases, Baltimore, MD, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|